The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
Quick apply
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
Quick apply
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
Redwood City, CA · On-site +1
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
Quick apply
Redwood City, CA · On-site +1
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
Quick apply
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
Quick apply
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
Quick apply
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
Quick apply
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
Quick apply
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
Quick apply
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
Quick apply
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
Redwood City, CA · On-site
$112K - $153K/yr
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
Quick apply
Redwood City, CA · On-site
$112K - $153K/yr
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and ...
Assess to professional development tools, education resources and free CME our Institute ... The Allman Brothers Band Museum at the Big House shows memorabilia in the rock band's former home.
Assess to professional development tools, education resources and free CME our Institute ... The Allman Brothers Band Museum at the Big House shows memorabilia in the rock band's former home.
... our Institute Leadership and growth opportunities Responsibilities: Collaborate with experts in ... The Allman Brothers Band Museum at the Big House shows memorabilia in the rock band's former home.
... our Institute Leadership and growth opportunities Responsibilities: Collaborate with experts in ... The Allman Brothers Band Museum at the Big House shows memorabilia in the rock band's former home.
Our Oncology Services are part of the Levine Cancer Institute, recently named by US News and World ... to musical legends the Allman Brothers Band and Otis Redding offers many art and cultural ...
Our Oncology Services are part of the Levine Cancer Institute, recently named by US News and World ... to musical legends the Allman Brothers Band and Otis Redding offers many art and cultural ...

Full-time
Posted 2 days ago
The Allman Institute is a translational research organization applying personalized medicine to treat severe and historically difficult-to-treat diseases, beginning with pulmonary fibrosis and chronic lung transplant dysfunction. The Institute combines deep molecular profiling, longitudinal clinical data, and a pragmatic mix of mechanism-guided and large-scale empirical approaches to accelerate therapeutic discovery and translation.
We pursue an ambitious and pragmatic, modality-agnostic therapeutic strategy spanning genetic medicines, molecular and pharmacologic therapies, cell and immune-based interventions, and engineered biological systems, in close collaboration with leading academic and biotech partners across the U.S. and abroad. The Institute is established as a nonprofit, backed by substantial long-term capital committed directly to the mission. Where strategically valuable, we may pursue mission-aligned for-profit ventures, spin-outs, and partnerships to accelerate therapeutic development and patient impact.
We are a small but rapidly growing team of approximately 20, scaling to 40–50 over the next year across labs and offices in Redwood City, CA and Cambridge, MA, driven by scientific rigor, translational urgency, and a patient-anchored mandate.
We are seeking a Lung Transplant Program Lead to lead project management and scientific coordination of the Institute's lung transplantation workstream. This role will serve as the dedicated owner of an effort that is currently early in its development, bringing structure, momentum, and synthesis to research and clinical activities that span multiple internal teams and external collaborators. The Program Lead will work closely with Institute leadership and serve as a primary point of contact for clinical and transplant teams.
This position may be remote, hybrid, or on-site depending on candidate location and Institute needs. Candidates based in the San Francisco Bay Area or Boston/Cambridge area are of particular interest, though strong candidates in other U.S. locations will also be considered. Some travel to clinical sites, collaborator institutions, and Institute locations may be required.
This role is well suited to someone who combines scientific fluency in immunology with strong project management instincts and a collaborative orientation. The Lung Transplant Program Lead is expected to enable communication and coordination between researchers, clinicians, and operational teams and bring together an ambitious program. and helping the Institute deliver on a dual mandate of optimizing clinical transplant outcomes and enabling novel research approaches in transplant immunology.